A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment
Clinical trial NCT06677255 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06677255
- Sponsor
- Wuhan Optics Valley Vcanbiopharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-12-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.